Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BaiDiZiYin + ShenQiYiFei
- Development stage
- Unknown
- Administration
- Oral
01
Overview
BaiDiZiYin + ShenQiYiFei is a combination of two traditional Chinese medicine (TCM) formulations—BaidiZiyin Pill and ShenqiYifei Pill—used as adjunctive treatments in pulmonary tuberculosis. These herbal formulas are designed to support conventional anti-tuberculosis therapy by potentially enhancing immune function and improving clinical outcomes. The exact mechanisms of action are not fully elucidated but are believed to involve immunomodulation and support of respiratory health according to TCM principles. Clinical studies are ongoing to further evaluate their efficacy and safety in this context[1][4][7][8].
- Brand names
- Bai Di Zi Yin WanShen Qi Yi Fei Wan
- Other names
- BaidiZiyin PillShenqiYifei Pill
Beyond the preview
Go deeper on BaiDiZiYin + ShenQiYiFei.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BaiDiZiYin + ShenQiYiFei.